SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-012940
Filing Date
2022-05-12
Accepted
2022-05-12 09:20:59
Documents
68
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 759104
2 ex31-1.htm EX-31.1 19359
3 ex31-2.htm EX-31.2 19014
4 ex32-1.htm EX-32.1 7672
  Complete submission text file 0001493152-22-012940.txt   4018702

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pulm-20220331.xsd EX-101.SCH 39070
6 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pulm-20220331_cal.xml EX-101.CAL 50982
7 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pulm-20220331_def.xml EX-101.DEF 133331
8 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pulm-20220331_lab.xml EX-101.LAB 297940
9 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pulm-20220331_pre.xml EX-101.PRE 223109
62 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 547554
Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

IRS No.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36199 | Film No.: 22916016
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences